J Korean Med Assoc.  2011 Jun;54(6):646-652. 10.5124/jkma.2011.54.6.646.

The burden of disease in Korea

• Oh IH
• Yoon SJ
• Kim EJ

• KMID: 2190756
• DOI: http://doi.org/10.5124/jkma.2011.54.6.646

Abstract

The disability adjusted life year (DALY), a single indicator of the burden of disease, is widely used to measure the burden of diseases, injuries, and risk factors. In this study, we review the relative sizes of the burden of disease worldwide and the characteristics of the burden of disease of the Korean population. Future research directions for study of the burden of disease in Korea are also suggested. In the Korean population, diabetes mellitus was the leading cause of the burden of disease (970 DALYs per 100,000 population) in 2002, followed by cerebrovascular disease (937 DALYs per 100,000 population) and asthma (709 DALYs per 100,000 population), which differed with the leading causes of the burden of disease globally: unipolar depressive disorder, ischemic heart disease, and cerebrovascular disease. In 2007, cirrhosis of the liver in males and cerebrovascular disease in females became the leading causes of the burden of disease of the Korean population with the epidemiologic transition. Despite the methodological difference with global burden of disease study, these findings represent the characteristics of the burden of disease in Korea. Though many studies have been conducted to measure the burden of disease in Korea, there is a need to go beyond these to combine policymaking for resource allocation, such as cost effectiveness analysis, with burden of disease studies.

Keyword

Disability adjusted life year; Cost of illness; Korea

MeSH Terms

Asthma
Cost of Illness
Cost-Benefit Analysis
Depressive Disorder
Diabetes Mellitus
Female
Fibrosis
Humans
Korea
Liver
Male
Myocardial Ischemia
Quality-Adjusted Life Years
Resource Allocation
Risk Factors

Figure

• 

  Figure 1 Top twenties diseases determined by disability adjusted life year (DALY) s in Korean population in 2002 (DALYs due to injuries are excluded).

Reference

1. World Health Organization. Global health risks: mortality and burden of disease attributable to selected major risks. 2009. Geneva: World Health Organization.

2. Yoon SJ, Bae SC. Current scope and perspective of burden of disease study based on health related quality of life. J Korean Med Assoc. 2004. 47:600–602.

3. Yoon SJ. Composite health indicators for mortality and morbidity. J Korean Med Assoc. 1999. 42:1175–1181.

4. Murray CJ. Quantifying the burden of disease: the technical basis for disability-adjusted life years. Bull World Health Organ. 1994. 72:429–445.

5. Lee H, Yoon SJ, Ahn HS. Measuring the burden of major cancers due to smoking in Korea. Cancer Sci. 2006. 97:530–534.

6. Shin YS, Yoon SJ, Park HJ. The method for burden of disease: for evidence based health policy making. 2004. Seoul: Kyungmunsa.

7. Global burden of disease [Internet]. World Health Organization. 2011. cited 2011 May 20. Geneva: World Health Organization;Available from: http://www.who.int/healthinfo/global_burden_disease/en/.

8. Murray CJ, Lopez AD. The global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020. 1996. Boston: Havard University Press.

9. Mathers CD, Ezzati M, Lopez AD. Measuring the burden of neglected tropical diseases: the global burden of disease framework. PLoS Negl Trop Dis. 2007. 1:e114.

10. Mathers C, Fat DM, Boerma J. The global burden of disease: 2004 update. 2008. Geneva: World Health Organization.

11. Mont D. Measuring health and disability. Lancet. 2007. 369:1658–1663.

12. Anand S, Hanson K. Disability-adjusted life years: a critical review. J Health Econ. 1997. 16:685–702.

13. Lake RJ, Cressey PJ, Campbell DM, Oakley E. Risk ranking for foodborne microbial hazards in New Zealand: burden of disease estimates. Risk Anal. 2010. 30:743–752.

14. Mooney G, Irwig L, Leeder S. Priority setting in health care: unburdening from the burden of disease. Aust N Z J Public Health. 1997. 21:680–681.

15. Kim YM, Kim JW, Lee HJ. Burden of disease attributable to air pollutants from municipal solid waste incinerators in Seoul, Korea: a source-specific approach for environmental burden of disease. Sci Total Environ. 2011. 409:2019–2028.

16. Lee H, Yoon SJ, Ahn HS, Moon OR. Estimation of potential health gains from reducing multiple risk factors of stroke in Korea. Public Health. 2007. 121:774–780.

17. Park JH, Yoon SJ, Lee HY, Cho HS, Lee JY, Eun SJ, Park JH, Kim Y, Kim YI, Shin YS. Estimating the burden of psychiatric disorder in Korea. J Prev Med Public Health. 2006. 39:39–45.

18. Bae SC, Lee SI, Yoon SJ, Yim J, Hong DH, Do YK, Lee JY, Park JH, Eun SJ, Park JH, Jung SH, Jo MW, Hwang IA, Park KS, Kim HJ. A study on improvement of health-related quality of life by measurement of disease burden in Korea. 2005. Seoul: Ministry of Health and Welfare.

19. Yoon SJ, Bae SC, Lee SI, Chang H, Jo HS, Sung JH, Park JH, Lee JY, Shin Y. Measuring the burden of disease in Korea. J Korean Med Sci. 2007. 22:518–523.

20. Yoon SJ, Kim EJ, Kim HJ, Kim SY, Jo MW, Hwang RI, Hong SW. A study on research methodology and long-term planning regarding estimating of economic burden of major diseases in Korea. 2009. Seoul: Korean Centers for Disease Control and Prevention.

21. Park JH, Shin Y, Lee SY, Lee SI. Antihypertensive drug medication adherence and its affecting factors in South Korea. Int J Cardiol. 2008. 128:392–398.

22. Hutubessy RC, Baltussen RM, Torres-Edejer TT, Evans DB. Generalised cost-effectiveness analysis: an aid to decision making in health. Appl Health Econ Health Policy. 2002. 1:89–95.